Skin Lesion
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Pulse BiosciencesCA - Hayward
2 programsCellFX SystemN/A1 trial
Nano-Pulse Stimulation DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pulse BiosciencesCellFX System
Pulse BiosciencesNano-Pulse Stimulation Device
Clinical Trials (2)
Total enrollment: 132 patients across 2 trials
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions
Start: Sep 2020Est. completion: Nov 202160 patients
N/ACompleted
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia
Start: Jun 2018Est. completion: Nov 201872 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space